U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07473765) titled 'Virtual Reality for Anxiety Management in Persons With Amyotrophic Lateral Sclerosis' on March 11.
Brief Summary: Virtual Reality (VR) is gaining traction as a new and innovative leisure to augment healthcare services. Several benefits of the leisure experience, such as distraction and full sensory immersion, have demonstrated a potential to significantly impact the field of healthcare through pain reduction, anxiety reduction, and is seen as an innovative approach to motor learning. Persons with ALS (pwALS) have a high prevalence of anxiety over the course of their illness, which has a negative impact on their quality of life, and...